Leader in Clinical Pharmacogenomics Named Dean of Rosalind Franklin University’s College of Pharmacy

Press Releases

Jan 31, 2024

NORTH CHICAGO, Ill., Jan. 31, 2024 /PRNewswire/ — Kristin Wiisanen, PharmD, FAPhA, FCCP, is the new dean of the College of Pharmacy at Rosalind Franklin University of Medicine and Science. Named to the post after a national search, Dr. Wiisanen is a national leader in clinical pharmacogenomics, a field that works to improve the safety and efficacy of drugs by incorporating genetic information.

Dr. Kristin Wiisanen plans to “nurture a culture where learning explores all possibilities for pharmacy’s future.”

Dr. Wiisanen joined RFU in October from the University of Florida College of Pharmacy, where she served as associate dean for entrepreneurial programs, associate director of UF Health’s precision medicine program and director of the graduate program in precision medicine. She also served as a clinical professor in the Department of Pharmacotherapy and Translational Research.

“Dr. Wiisanen brings a deep level of experience in a multitude of crucial areas for our College of Pharmacy: teaching, research, clinical practice, administration, enrollment, partnerships, and curricular design, assessment and accreditation,” said RFU President and CEO Dr. Wendy Rheault. “She is uniquely positioned to support and enhance student learning and prepare practice-ready graduates.”

At RFU, Dr. Wiisanen plans to “nurture a culture where learning explores all possibilities for pharmacy’s future.”

“RFU’s mission to deliver interprofessional education separates the College of Pharmacy from other programs,” she said. “We build on that mission by emphasizing foundations for tomorrow’s pharmacist, including pharmacogenomics, artificial intelligence, industry and big data.

“More pharmacists in the field are working on teams using genomics and other data, and we prepare our graduates to flow seamlessly into the profession’s expanding scope of practice, including community pharmacy, health systems, industry, academia and public health.”

Dr. Wiisanen earned her Doctor of Pharmacy degree from UF and completed a community pharmacy practice residency at Virginia Commonwealth University School of Pharmacy. Early in her career, she worked as a clinical pharmacist in both private and community health center settings.

She has been an investigator on several research grants throughout her career, including projects exploring genomic medicine funded by the National Institutes of Health and other agencies.

ABOUT ROSALIND FRANKLIN UNIVERSITY
Rosalind Franklin University of Medicine and Science encompasses the Chicago Medical School, College of Health Professions, College of Nursing, the Dr. William M. Scholl College of Podiatric Medicine and School of Graduate and Postdoctoral Studies. The College of Pharmacy, the only such college in Chicago’s north suburbs, was founded in 2011. Learn more at rosalind franklin.edu.

Office of Marketing and Communications
dan.moran@rosalindfranklin.edu

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/leader-in-clinical-pharmacogenomics-named-dean-of-rosalind-franklin-universitys-college-of-pharmacy-302049763.html

SOURCE Rosalind Franklin University of Medicine and Science

YOU MAY ALSO LIKE

Peer Unveils a Groundbreaking Virtual Universe to…

NORTH CHICAGO, Ill., Jan. 31, 2024 /PRNewswire/ -- Kristin Wiisanen, PharmD, FAPhA, FCCP, is the new dean of the College of Pharmacy at Rosalind Franklin University…

read more

Vantiq, Telemedicine Solutions and NTT DATA Announce…

NORTH CHICAGO, Ill., Jan. 31, 2024 /PRNewswire/ -- Kristin Wiisanen, PharmD, FAPhA, FCCP, is the new dean of the College of Pharmacy at Rosalind Franklin University…

read more

Synthetic Identities and Deep Fakes: The New…

NORTH CHICAGO, Ill., Jan. 31, 2024 /PRNewswire/ -- Kristin Wiisanen, PharmD, FAPhA, FCCP, is the new dean of the College of Pharmacy at Rosalind Franklin University…

read more